Thioridazine and arrhythmia

NEW YORK, August 3 (Praxis Press) The antipsychotic drug, Mellaril (thioridazine) has been shown to prolong patients' QTc interval, which can lead to a type of ventricular tachycardia known as torsades de pointes and potentially sudden death. At the request of the US Food and Drug administration (FDA), the manufacturer of the drug, Novartis, has now added a black box warning on the drug's label in order to alert physicians to its tendency of prolonging a patient's heartbeat interval. Now Mellari

August 8, 2000

NEW YORK, August 3 (Praxis Press) The antipsychotic drug, Mellaril (thioridazine) has been shown to prolong patients' QTc interval, which can lead to a type of ventricular tachycardia known as torsades de pointes and potentially sudden death. At the request of the US Food and Drug administration (FDA), the manufacturer of the drug, Novartis, has now added a black box warning on the drug's label in order to alert physicians to its tendency of prolonging a patient's heartbeat interval. Now Mellaril is indicated only for patients with schizophrenia who either cannot tolerate other antipsychotic drugs or who fail to respond to them.

Popular Now

  1. Symmetrical Eyes Indicate Dyslexia
  2. German Scientists Resign from Elsevier Journals’ Editorial Boards
  3. Germany Sees Drastic Decrease in Insects
  4. Swapping Cigarettes for Vaping
    The Scientist Swapping Cigarettes for Vaping

    New evidence suggests e-cigarettes are not without risks to human health, but can be useful in getting people to kick their smoking habit.

RayBiotech